Background: The definition of significant stenosis (SS) remains controversial. Methods: We retrospectively reviewed 1,040 consultations. SS was defined in the presence of clinical and echo-Doppler (DDU) criteria: Qa <500 mL/min or Qa decrease >25%; RI >0.7 in the feeding artery or absolute minimal luminal stenosis diameter <2.0 mm. Stenosis without any additional criteria were considered borderline stenosis (BS). Results: Two hundred twenty-one arteriovenous fistulas (AVFs) were included: 58.8% had SS, 18.6% had BS, and 22.6% had no dysfunctional access (ND). SS had a significantly higher thrombotic events than BS and ND (13.1 vs. 4.4%, p = 0.018). The annual thrombosis rate was 0.007, 0.037, and 0.004 in the ND, SS, and BS, respectively. AVF cumulative survival at 5 years was significantly lower in SS (89.5%) compared to BS (100%) and ND (97.4%; p = 0.03). BS had an HR for AVF failure of 1.1, p = 0.955, while the SS presented an HR of 5.9, p = 0.09. Conclusion: AVF clinical monitoring with additional DDU criteria appear to be appropriate for therapeutic referral.

Keywords:
Significant stenosis, Borderline stenosis, Arteriovenous fistula, Thrombosis
1.
Fahrtash F, Kairaitis L, Gruenewald S, Spicer T, Sidrak H, Fletcher J, Allen R, Swinnen J: Defining a significant stenosis in an -autologous radio-cephalic arteriovenous fistula for hemodialysis. Semin Dial 2011; 24: 231–238.
2.
Malik J, Kudlicka J, Novakova L, Adamec J, Malikova H, Kavan J: Surveillance of arteriovenous accesses with the use of duplex Doppler ultrasonography. J Vasc Access 2014; 15(suppl 7):S28–S32.
3.
National Kidney Foundation: KDOQI Clinical Practice Guidelines for Vascular Access 2006. Am J Kidney Dis 2006; 48(suppl S1):S176–S273.
4.
Malik J, Slavikova M, Svobodova J, Tuka V: Regular ultrasonographic screening significantly prolongs patency of PTFE grafts. Kidney Int 2005; 67: 1554–1558.
5.
Besarab A, Asif A, Roy-Chaudhury P, Spergel LM, Ravani P: The native arteriovenous fistula in 2007. Surveillance and monitoring. J Nephrol 2007; 20: 656–667.
6.
Paulson WD, Moist L, Lok CE: Vascular access surveillance: an ongoing controversy. Kidney Int 2012; 81: 132–142.
7.
Gadallah MF, Paulson WD, Vickers B, Work J: Accuracy of Doppler ultrasound in diagnosing anatomic stenosis of hemodialysis arteriovenous access as compared with fistulography. Am J Kidney Dis 1998; 32: 273–277.
8.
Malik J, Slavikova M, Maskova J, Hradec J: Comparison of ultrasound findings of significant dialysis access stenosis with angiography. Cor Vasa 2002; 44: 68–72.
9.
Barreto P, Almeida P, de Matos N, Queirós JA, Pinheiro J, Silva F, Carvalho T, Almeida R, Cabrita A: Preoperative vessel mapping in chronic kidney disease patients – a center experience. J Vasc Access 2016; 17: 320–327.
10.
Oakes DD, Sherck JP, Cobb LF: Surgical salvage of failed radiocephalic arteriovenous fistulae: techniques and results in 29 patients. Kidney Int 1998; 53: 480–487.
11.
Ponce P, Marcelli D, Scholz C, Wehmeyer W, Gonçalves P, Grassmann A, Brand K, Canaud B: Does the extracorporeal blood flow affect survival of the arteriovenous vascular access? Hemodial Int 2015; 19: 314–322.
12.
Fahrtash F, Kairaitis L, Gruenewald S, Spicer T, Sidrak H, Fletcher J, Allen R, Swinnen J: Defining a significant stenosis in an -autologous radio-cephalic arteriovenous fistula for hemodialysis. Semin Dial 2011; 24: 231–238.
13.
Vascular Access 2006 Work Group: Clinical practice guidelines for vascular access. Am J Kidney Dis 2006; 48(suppl 1):S248–S273.
14.
Tuka V, Slavikova M, Krupickova Z, Mokrejsova M, Chytilova E, Malik J: Short-term outcomes of borderline stenoses in vascular accesses with PTFE grafts. Nephrol Dial Transplant 2009; 24: 3193–3197.
15.
White JJ, Ram SJ, Jones SA, Schwab SJ, Paulson WD: Influence of luminal diameters on flow surveillance of hemodialysis grafts: insights from a mathematical model. Clin J Am Soc Nephrol 2006; 1: 972–978.
16.
Lok CE, Sontrop JM, Tomlinson G, Rajan D, Cattral M, Oreopoulos G, Harris J, Moist L: Cumulative patency of contemporary fistulas versus grafts (2000–2010). Clin J Am Soc Nephrol 2013; 8: 810–818.
17.
Shintaku SKH, Moriishi M, Agoh R, Bansyodani M, Tsuchiya S: Flow volume and resistance index help Predicted early access failure in arteriovenous fistulae. J Vasc Access 2013; 14: 61–62.
18.
Robbin ML, Oser RF, Allon M, Clements MW, Dockery J, Weber TM, Hamrick-Waller KM, Smith JK, Jones BC, Morgan DE, Saddekni S: Hemodialysis access graft stenosis: US detection. Radiology 1998; 208: 655–661.
19.
Shenoy S, Hoganson DM, Hinkel CJ, Chen X, Agarwal RK: Validation of computational fluid dynamics-based analysis to evaluate hemodynamic significance of access stenosis. J Vasc Access 2014; 15: 409–414.
20.
Beathard GA: Angioplasty for arteriovenous grafts and fistulae. Semin Nephrol 2002; 22: 202–210.
21.
Erickson KF, Mell MW, Winkelmayer WC, Chertow GM, Bhattacharya J: Provider Visit Frequency and Vascular Access Interventions in Hemodialysis. Clin J Am SocNephrol 2015; 10: 269–277.
22.
Sands JJ, Jabyac PA, Miranda CL, Kapsick BJ: Intervention based on monthly monitoring decreases hemodialysis access thrombosis. ASAIO J 1999; 45: 147–150.
23.
Smits JH, van der Linden J, Hagen EC, Modderkolk-Cammeraat EC, Feith GW, Koomans HA, van den Dorpel MA, Blankestijn PJ: Graft surveillance: venous pressure, access flow, or the combination? Kidney Int 2001; 59: 1551–1558.
24.
Ram SJ, Work J, Caldito GC, Eason JM, Pervez A, Paulson WD: A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney Int 2003; 64: 272–280.
25.
Moist LM, Churchill DN, House AA, Millward SF, Elliott JE, Kribs SW, DeYoung WJ, Blythe L, Stitt LW, Lindsay RM: Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. J Am Soc Nephrol 2003; 14: 2645–2653.
26.
Tessitore N, Lipari G, Poli A, Bedogna V, Baggio E, Loschiavo C, Mansueto G, Lupo A: Can blood flow surveillance and pre-emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study. Nephrol Dial Transplant 2004; 19: 2325–2333.
27.
Polkinghorne KR, Lau KK, Saunder A, Atkins RC, Kerr PG: Does monthly native arteriovenous fistula blood-flow surveillance detect significant stenosis–a randomized controlled trial. Nephrol Dial Transplant 2006; 21: 2498–2506.
28.
Scaffaro LA, Bettio JA, Cavazzola SA, Campos BT, Burmeister JE, Pereira RM, Barcellos CS, Caramori P: Maintenance of hemodialysis arteriovenous fistulas by an interventional strategy: clinical and duplex ultrasonographic surveillance followed by transluminal angioplasty. J Ultrasound Med 2009; 28: 1159–1165.
29.
Ibeas JL: Monitorización del acceso vascular: ¿quo vadis?. NefroPlus 2011; 4: 11–20.
30.
Tessitore N, Bedogna V, Verlato G, Poli A: The rise and fall of access blood flow surveillance in arteriovenous fistulas. Semin Dial 2014; 27: 108–118.
31.
Paulson WD, Moist L, Lok CE: Vascular access surveillance: an ongoing controversy. Kidney Int 2012; 81: 132–142.
32.
Tessitore N, Bedogna V, Poli A, Lipari G, Pertile P, Baggio E, Contro A, Criscenti P, Mansueto G, Lupo A: Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial. Nephrol Dial Transplant 2014; 29: 179–187.
33.
Tordoir JH: Dialysis: Early pre-emptive intervention might reduce AVF access loss. Nat Rev Nephrol 2014; 10: 9–10.
34.
Tonelli M, James M, Wiebe N, Jindal K, Hemmelgarn B; Alberta Kidney Disease Network: Ultrasound monitoring to detect access stenosis in hemodialysis patients: a systematic review. Am J Kidney Dis 2008; 51: 630–640.
35.
Muchayi T, Salman L, Tamariz LJ, Asif A, Rizvi A, Lenz O, Vazquez-Padron RI, Tabbara M, Contreras G: A meta-analysis of randomized clinical trials assessing hemodialysis access thrombosis based on access flow monitoring: where do we stand? Semin Dial 2015; 28:E23–E29.
36.
Kudlicka J, Kavan J, Tuka V, Malik J: More precise diagnosis of access stenosis: ultrasonography versus angiography. J Vasc Access 2012; 13: 310–314.
37.
Salman L, Ladino M, Alex M, et al: Accuracy of ultrasound in the detection of inflow stenosis of arteriovenous fistulae: results of a prospective study. Semin Dial 2010; 23: 117–121.
38.
Tessitore N, Bedogna V, Melilli E, et al: In search of an optimal bedside screening program for arteriovenous fistula stenosis. Clin J Am SocNephrol 2011; 6: 819–826.
39.
Allon M, Robbin ML: Hemodialysis vascular access monitoring: current concepts. Hemodial Int 2009; 13: 153–162.
40.
Robbin ML, Oser RF, Lee JY, et al: Randomized comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes. Kidney Int 2006; 69: 730–735.
41.
Salman L, Vazquez-Padron R, et al: Measurement of vessel diameter during angioplasty: are we accurately performing this task? Semin Dial 2014; 27:E38–E41.
42.
Matsui S, Nakai K, Taniguchi T, Nagai T, Yokomatsu T, Kono Y, Mizoguchi T, Miki S, Yoshida A, Nagao K, Tsuji H, Ono S: Systematic evaluation of vascular access by color-Doppler ultrasound decreased the incidence of emergent vascular access intervention therapy and X-ray exposure time: a single-center observational study. Ther Apher Dial 2012; 16: 169–172.
43.
Erickson SJ, Mewissen MW, Foley WD, et al: Stenosis of the internal carotid artery: assessment using color Doppler imaging compared with angiography. AJR Am J Roentgenol 1989; 152: 1299–1305.
44.
Polak JF, Dobkin GR, O’Leary DH, et al: Internal carotid artery stenosis: accuracy and reproducibility of color-Doppler-assisted duplex imaging. Radiology 1989; 173: 793–798.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.